Theresa A. Deisher, Ph.D., graduated from Stanford University School of Medicine with a doctoral degree in Molecular & Cellular Physiology. She has over 47 issued patents and 4 discoveries in clinical trials. Dr. Deisher has extensive scientific and management experience in the commercial biotechnology field at Genentech, Repligen, ZymoGenetics, Immunex, and Amgen and has led a team of innovative scientists at AVM Biotechnology – a clinical stage company – since 2008.
Theresa Deisher, PhD
Share: